Chemoprophylaxis use and the risk of malaria in travelers to Nepal

Journal of Travel Medicine

Volumn 10, Issue 2, 2003, Pages 100-105

  Cave, William ^a   Pandey, Prativa ^a   Osrin, David ^b   Shlim, David R ^c  

^a CIWEC Hospital and Travel Medicine Center   (Nepal)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Jackson Hole Travel and Tropical Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CHLOROQUINE; DOXYCYCLINE; MEFLOQUINE; PROGUANIL;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CHILD; DENMARK; DISEASE TRANSMISSION; FEMALE; GERMANY; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; NEPAL; QUESTIONNAIRE; UNITED KINGDOM;

EID: 0037349436     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2003.31761     Document Type: Article

References (13)

1. Department of Health Services. The Annual Internal Assessment of Malaria Control Activities 1999. His Majesty's Government, Nepal, Ministry of Health.
2. Department of Health Services. Annual Report 1999-2000. His Majesty's Government, Nepal, Ministry of Health.
3. PHLS Malaria Reference Laboratory, UK. Database on imported malaria: annual statistics. Circulated document. Unpublished.
4. Centers for Disease Control and Prevention, Atlanta. Malaria information for travelers to the Indian subcontinent. April 2001. Available at: http://www.cdc.gov/travel/regional-malaria/indianrg.htm Accessed January 30, 2002.
5. World Health Organization. International travel and health - Nepal: vaccine requirements and health advice. January 2001. Available at: http://www.who.int/ith/english/nepal.htm Accessed January 30, 2002.
6. Guidelines for malaria prevention in travelers from the United Kingdom. Advisory Committee on Malaria Prevention. Commun Dis Public Health 2001; 4:84-101.
7. Landelijke Coordinatiestructuur Infectieziektenbestijding. (National Coordination Centre for Communicable Disease Outbreak Management), The Netherlands. Available at: http://www.lci.lcr.nl/protocollen/malaria/frameset_Ici.htm Accessed February 5, 2002.
8. Hoebe C, de Munter J, Thijs C. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis. Eur J Clin Pharmacol 1997; 52:269-275.
9. Behrens RH, Taylor RB, Pryce DI, Low AS. Chemoprophylaxis compliance in travellers with malaria. J Travel Med 1998; 5:92-94.
10. Chatterjee S. Compliance of malaria chemoprophylaxis among travelers to India. J Travel Med 1999; 6:7-11.
11. Laver SM, Wetzels J, Behrens RH. Knowledge of malaria, risk perception and compliance with prophylaxis and personal and environmental preventive measures in travellers exiting Zimbabwe from Harare and Victoria Falls International airports. J Travel Med 2001; 8:298-303.
12. Banerjee D, Stanley PJ. Malaria chemoprophylaxis in UK general practitioners travelling to South Asia. J Travel Med 2001; 8:173-175.
13. Immigration Office, Tribhuvan International Airport. His Majesties Government, Nepal, Department of Immigration. Published in Nepal Tourism Board Newsletter; vol 3, (6). January 2002.